adapalene has been researched along with Melanoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Anaya-Ruiz, M; Perez-Santos, M | 1 |
| Janssen, N; Pawelec, G; Shipp, C; Sinnberg, T; Speigl, L; Weide, B | 1 |
| Nasir, A | 1 |
| Kasemeier-Kulesa, JC; Kulesa, PM | 1 |
| Berti, E; Cavicchini, S; Coggi, A; Del Gobbo, A; Fanoni, D; Ferrero, S; Gianotti, R; Guanziroli, E; Venegoni, L | 1 |
| Bu, W; Li, H; Li, L; Ma, P; Qian, K; Tao, L; Wang, C; Wei, J; Zhang, M | 1 |
| Cohen, C; Gonzalez, RS; Lawson, D; Mohamed, A; Wang, J | 1 |
| Anichini, A; Baldassari, P; Bersani, I; Maurichi, A; Molla, A; Mortarini, R; Perotti, V; Santinami, M; Vegetti, C | 1 |
| Beck, AH; Boiko, AD; Hachey, SJ; Han, A; Lakatos, A; Ngo, M; Sahoo, D; Weiskopf, K; Weissman, IL | 1 |
| Aldrich, W; Joshi, P; Kooshki, M; Singh, AD; Triozzi, PL; Varghai, D; Zborowski, M | 1 |
| Gambichler, T; Petig, AL; Stockfleth, E; Stücker, M | 1 |
| Foster, HR; Fullen, DR; Johnson, TM; Morrison, SJ; Quintana, E; Sabel, MS; Shackleton, M | 1 |
| Chandrasekaran, S; DeLouise, LA | 1 |
13 other study(ies) available for adapalene and Melanoma
| Article | Year |
|---|---|
Drug repurposing of adapalene for melanoma treatment.
Topics: Acne Vulgaris; Adapalene; Cell Line; Drug Repositioning; Humans; Melanoma | 2022 |
Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells
Topics: AC133 Antigen; Adapalene; Antigens, CD; Biomarkers, Tumor; Cell Line, Tumor; Humans; Melanoma; Neoplastic Stem Cells; Nestin; Tumor Microenvironment | 2023 |
Can Adapalene Be Repurposed For Melanoma?
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Gels; Humans; Melanoma; Treatment Outcome | 2023 |
The convergent roles of CD271/p75 in neural crest-derived melanoma plasticity.
Topics: Adapalene; Adaptor Proteins, Signal Transducing; Animals; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Embryonic Stem Cells; Humans; Melanocytes; Melanoma; Mice; Multipotent Stem Cells; Neural Crest; Neuronal Plasticity; Transcription Factors | 2018 |
Immunohistochemical expression and prognostic role of CD10, CD271 and Nestin in primary and recurrent cutaneous melanoma.
Topics: Adapalene; Biomarkers, Tumor; Humans; Melanoma; Neoplasm Recurrence, Local; Neprilysin; Nerve Tissue Proteins; Nestin; Prognosis; Receptors, Nerve Growth Factor; Skin Neoplasms | 2021 |
Adapalene suppressed the proliferation of melanoma cells by S-phase arrest and subsequent apoptosis via induction of DNA damage.
Topics: Adapalene; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA Repair; Humans; Melanoma; Receptors, Retinoic Acid; S Phase Cell Cycle Checkpoints | 2019 |
Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
Topics: Adapalene; Biomarkers, Tumor; Humans; Lymphatic Metastasis; Melanoma; Naphthalenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Stem Cells; Prognosis; Proto-Oncogene Proteins c-kit; Skin Neoplasms; SOXE Transcription Factors; Survival Analysis; Tissue Array Analysis; Treatment Outcome | 2014 |
NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Topics: Adapalene; Cell Dedifferentiation; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gene Silencing; Homeodomain Proteins; Humans; Melanoma; Melanoma-Specific Antigens; Microphthalmia-Associated Transcription Factor; NFATC Transcription Factors; POU Domain Factors; Proto-Oncogene Proteins c-myc; T-Lymphocytes, Cytotoxic; Tumor Escape | 2016 |
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts.
Topics: Adapalene; CD47 Antigen; Cell Line, Tumor; Heterografts; Humans; Macrophages; Melanoma; Neoplasm Metastasis; Phagocytosis; Vascular Endothelial Growth Factor Receptor-1 | 2016 |
Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.
Topics: Adapalene; Cytotoxicity, Immunologic; Gene Expression Regulation, Neoplastic; Humans; Killer Cells, Natural; Melanocytes; Melanoma; MicroRNAs; Neoplastic Stem Cells; Transfection; Uveal Neoplasms | 2016 |
Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Topics: Adapalene; Adolescent; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Skin Neoplasms; SOXE Transcription Factors; Survival Rate; Young Adult | 2016 |
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.
Topics: Adapalene; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Cell Proliferation; Humans; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Naphthalenes; Neoplasm Metastasis; Phenotype; Transplantation, Heterologous | 2010 |
Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
Topics: Adapalene; Antigens, CD20; Biomarkers, Tumor; Cell Adhesion; Cell Line, Tumor; Cell Shape; Cell Survival; Dimethylpolysiloxanes; Humans; Melanoma; Microbubbles; Naphthalenes; Neoplastic Stem Cells; Phenotype; Polystyrenes; Spheroids, Cellular; Tumor Stem Cell Assay | 2011 |